E-Learning

Why Is Larimar Therapeutics Stock Trading Lower On Monday?

On Monday, Larimar Therapeutics, Inc. (NASDAQ:LRMR) released initial data from the ongoing long-term OLE study evaluating daily subcutaneous injections of 25 mg of nomlabofusp self-administered or administered by a caregiver in participants with Friedreich’s Ataxia. Friedreich’s Ataxia is caused by a mutation in the FXN gene, which carries the code for the frataxin protein. Frataxin is important for the normal function of mitochondria, the energy-producing parts of cells At the time of data cut

Read more

UK Homebuilder Stocks Flash Buy Signal After Year-End Slump

(Bloomberg) -- British homebuilder stocks are flashing a key buy metric for the first time in more than a year, indicating a possible end to a slump spurred by concern that elevated mortgage rates will hamper demand.Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxHow California Sees the World, and ItselfLondon’s Tube Fares Are Set to Rise by 4.6% Next YearThe Bloomberg UK Homebuilder Index is trading at a price-to-book ratio of less than 1, loosely meaning the equit

Read more

ECB Broadly Comfortable With Market’s Rate-Cut Bets, Wunsch Says

(Bloomberg) -- Investor bets on how much lower the European Central Bank’s interest rates will have to fall are relatively consistent with policymakers’ own assessments, according to Governing Council member Pierre Wunsch.Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxHow California Sees the World, and ItselfLondon’s Tube Fares Are Set to Rise by 4.6% Next YearAsked about wagers on four to five more quarter-point cuts from the current 3% level, the Belgian official

Read more